These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 21527937)
1. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Magenta A; Cencioni C; Fasanaro P; Zaccagnini G; Greco S; Sarra-Ferraris G; Antonini A; Martelli F; Capogrossi MC Cell Death Differ; 2011 Oct; 18(10):1628-39. PubMed ID: 21527937 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1. Luo Z; Wen G; Wang G; Pu X; Ye S; Xu Q; Wang W; Xiao Q Stem Cells; 2013 Sep; 31(9):1749-62. PubMed ID: 23765923 [TBL] [Abstract][Full Text] [Related]
3. Oxidative Stress-Induced miR-200c Disrupts the Regulatory Loop Among SIRT1, FOXO1, and eNOS. Carlomosti F; D'Agostino M; Beji S; Torcinaro A; Rizzi R; Zaccagnini G; Maimone B; Di Stefano V; De Santa F; Cordisco S; Antonini A; Ciarapica R; Dellambra E; Martelli F; Avitabile D; Capogrossi MC; Magenta A Antioxid Redox Signal; 2017 Aug; 27(6):328-344. PubMed ID: 27960536 [TBL] [Abstract][Full Text] [Related]
5. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis. Shi D; Guo L; Sun X; Shang M; Meng D; Zhou X; Liu X; Zhao Y; Li J Sci Rep; 2020 Apr; 10(1):6657. PubMed ID: 32313093 [TBL] [Abstract][Full Text] [Related]
6. Sevoflurane protects against hepatic ischemia/reperfusion injury by modulating microRNA-200c regulation in mice. Wu Y; Gu C; Huang X Biomed Pharmacother; 2016 Dec; 84():1126-1136. PubMed ID: 27780142 [TBL] [Abstract][Full Text] [Related]
7. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer. Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544 [TBL] [Abstract][Full Text] [Related]
8. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Rajabi H; Alam M; Takahashi H; Kharbanda A; Guha M; Ahmad R; Kufe D Oncogene; 2014 Mar; 33(13):1680-9. PubMed ID: 23584475 [TBL] [Abstract][Full Text] [Related]
9. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Howe EN; Cochrane DR; Richer JK Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518 [TBL] [Abstract][Full Text] [Related]
10. The downregulation of miR-200c/141 promotes ZEB1/2 expression and gastric cancer progression. Zhou X; Wang Y; Shan B; Han J; Zhu H; Lv Y; Fan X; Sang M; Liu XD; Liu W Med Oncol; 2015 Jan; 32(1):428. PubMed ID: 25502084 [TBL] [Abstract][Full Text] [Related]
11. miR-200c inhibits invasion and migration in human colon cancer cells SW480/620 by targeting ZEB1. Chen ML; Liang LS; Wang XK Clin Exp Metastasis; 2012 Jun; 29(5):457-69. PubMed ID: 22407310 [TBL] [Abstract][Full Text] [Related]
12. The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression. Liu Y; Sánchez-Tilló E; Lu X; Huang L; Clem B; Telang S; Jenson AB; Cuatrecasas M; Chesney J; Postigo A; Dean DC J Biol Chem; 2014 Feb; 289(7):4116-25. PubMed ID: 24371144 [TBL] [Abstract][Full Text] [Related]
13. Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in breast cancer cells. Lobert S; Graichen ME; Morris K Biochemistry; 2013 Aug; 52(32):5482-90. PubMed ID: 23869586 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of miR-200c Restores Endothelial Function in Diabetic Mice Through Suppression of COX-2. Zhang H; Liu J; Qu D; Wang L; Luo JY; Lau CW; Liu P; Gao Z; Tipoe GL; Lee HK; Ng CF; Ma RC; Yao X; Huang Y Diabetes; 2016 May; 65(5):1196-207. PubMed ID: 26822089 [TBL] [Abstract][Full Text] [Related]
15. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma. Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572 [TBL] [Abstract][Full Text] [Related]
16. miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5. Chuang TD; Panda H; Luo X; Chegini N Endocr Relat Cancer; 2012 Aug; 19(4):541-56. PubMed ID: 22685266 [TBL] [Abstract][Full Text] [Related]
18. miR-200c enhances sensitivity of drug-resistant non-small cell lung cancer to gefitinib by suppression of PI3K/Akt signaling pathway and inhibites cell migration via targeting ZEB1. Zhou G; Zhang F; Guo Y; Huang J; Xie Y; Yue S; Chen M; Jiang H; Li M Biomed Pharmacother; 2017 Jan; 85():113-119. PubMed ID: 27930974 [TBL] [Abstract][Full Text] [Related]
19. Stable expression of miR-200c alone is sufficient to regulate TCF8 (ZEB1) and restore E-cadherin expression. Hurteau GJ; Carlson JA; Roos E; Brock GJ Cell Cycle; 2009 Jul; 8(13):2064-9. PubMed ID: 19502803 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1. Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]